  We predict vaccine efficacy with a measure of antigenic distance between
influenza A(H3N2) and candidate vaccine viruses based on amino acid
substitutions in the dominant epitopes. In 2016-2017, our model predicts 19%
efficacy compared to 20% observed. This tool assists candidate vaccine
selection by predicting human protection against circulating strains.
